Patent ID: 6767326
Filing Date: 2004-07-27
Classification: A61P,G16H,Y10S

Abstract:
A method for distributing a teratogenic drug to a patient in need of the drug while preventing foetal exposure to the drug, said method comprising:a. registering in a computer readable storage medium physicians permitted to prescribe said drug; b. providing said patient with counseling information concerning the teratogenic risks attendant to foetal exposure to said drug; c. obtaining the informed consent of said patient to receive said drug despite said risks; d. registering said patient in said medium, including information concerning the ability of said patient to become pregnant or to impregnate a female; e. upon a determination that said patient is capable of becoming pregnant, determining that said patient is not currently pregnant, and registering same in said medium; f. permitting said patient access to said drug only after consulting said medium to verify that said patient is either incapable of becoming pregnant or is not currently pregnant.